Evidence map›Paper›PMID 32804543›Full record

ArticleJCO clinical cancer informatics2020

Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform.

Mireia Crispin-Ortuzar, Marcel Gehrung, Stephan Ursprung, Andrew B Gill, Anne Y Warren, Lucian Beer, Ferdia A Gallagher, Thomas J Mitchell, Iosif A Mendichovszky, Andrew N Priest and 3 more

Open access · hybridAbstract read
In one paragraph

Article in JCO clinical cancer informatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. HyperpolarizedCancers · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Mireia Crispin-OrtuzarCancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Marcel GehrungCancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Stephan UrsprungCancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Andrew B GillDepartment of Radiology, University of Cambridge, Cambridge, United Kingdom.
Anne Y WarrenDepartment of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom.
Lucian BeerDepartment of Radiology, University of Cambridge, Cambridge, United Kingdom.
Ferdia A GallagherDepartment of Radiology, University of Cambridge, Cambridge, United Kingdom.
Thomas J MitchellDepartment of Surgery, University of Cambridge, Cambridge, United Kingdom.
Iosif A MendichovszkyDepartment of Radiology, University of Cambridge, Cambridge, United Kingdom.
Andrew N PriestDepartment of Radiology, University of Cambridge, Cambridge, United Kingdom.
Grant D StewartDepartment of Surgery, University of Cambridge, Cambridge, United Kingdom.
Evis SalaCancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Florian MarkowetzCancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GBCancer Research UK Cambridge Center · GBCambridge University Hospitals NHS Foundation Trust · GB

Funding

Cancer Research UK 16628Cancer Research UK 19274Cancer Research UK 27176Cancer Research UK 28290Cancer Research UK C14303/A17197Cancer Research UK C14303/A19274Cancer Research UK C19212/A16628Cancer Research UK C19212/A27150Cancer Research UK C19212/A911376Cancer Research UK C197/A16465Cancer Research UK C8742/A18097Cancer Research UK C9685/A25117Wellcome TrustWellcome Trust 095962
6 · The paper itself

Abstract

purposeSpatial heterogeneity of tumors is a major challenge in precision oncology. The relationship between molecular and imaging heterogeneity is still poorly understood because it relies on the accurate coregistration of medical images and tissue biopsies. Tumor molds can guide the localization of biopsies, but their creation is time consuming, technologically challenging, and difficult to interface with routine clinical practice. These hurdles have so far hindered the progress in the area of multiscale integration of tumor heterogeneity data.

methodsWe have developed an open-source computational framework to automatically produce patient-specific 3-dimensional-printed molds that can be used in the clinical setting. Our approach achieves accurate coregistration of sampling location between tissue and imaging, and integrates seamlessly with clinical, imaging, and pathology workflows.

resultsWe applied our framework to patients with renal cancer undergoing radical nephrectomy. We created personalized molds for 6 patients, obtaining Dice similarity coefficients between imaging and tissue sections ranging from 0.86 to 0.96 for tumor regions and between 0.70 and 0.76 for healthy kidneys. The framework required minimal manual intervention, producing the final mold design in just minutes, while automatically taking into account clinical considerations such as a preference for specific cutting planes.

conclusionOur work provides a robust and automated interface between imaging and tissue samples, enabling the development of clinical studies to probe tumor heterogeneity on multiple spatial scales.

Indexed as

Kidney NeoplasmsMagnetic Resonance ImagingBiopsyHumansPrecision Medicine

Identifiers

PMID32804543
PMCPMC7469624
OpenAlexW3061082507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.